Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, October 9, 2013

REFILE-BRIEF-Astex Pharmaceuticals responds to further misleading claims made by Sarissa Capital, (NASDAQ: ASTX)

Astex Pharmaceuticals Inc : * Says disappointed that Sarissa Capital continues to mislead Astex stockholders with information that is incomplete * Says $8.50 per share all-cash transaction with Otsuka was in the bestinterests of all Astex stockholders * Says no third parties have approached Astex with an interest to acquire thecompany * Source text for Eikon * Further company coverage

Shares of ASTX traded higher by 0.18% or $0.015/share to $8.50. In the past year, the shares have traded as low as $2.14 and as high as $9.39. On average, 3164080 shares of ASTX exchange hands on a given day and today's volume is recorded at 2391824.



Source